A group of German and Swiss researchers recently found that mismatch negativity (MMN) brain waves may identify people who are at risk for developing schizophrenia in the future. more...
After reviewing the findings of a six-week trial, the U.S. Food and Drug Administration (FDA) approved the drug paliperidone for the treatment of schizophrenia in adolescents, according to a recent article published by MedScape News. more...
Compared to mentally healthy youth, children who develop psychological disorders early in life may earn less money and struggle to sustain stable relationships over their lifetimes, according to a new study. more...